125 related articles for article (PubMed ID: 28934515)
21. Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH.
Ketterling RP; Wyatt WA; VanWier SA; Law M; Hodnefield JM; Hanson CA; Dewald GW
Leuk Res; 2002 Mar; 26(3):235-40. PubMed ID: 11792411
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients.
Romeo M; Chauffaille Mde L; Silva MR; Bahia DM; Kerbauy J
Leuk Res; 2002 Nov; 26(11):993-6. PubMed ID: 12363467
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.
Cioc AM; Wagner JE; MacMillan ML; DeFor T; Hirsch B
Am J Clin Pathol; 2010 Jan; 133(1):92-100. PubMed ID: 20023263
[TBL] [Abstract][Full Text] [Related]
24. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
[TBL] [Abstract][Full Text] [Related]
25. Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?
Costa D; Valera S; Carrió A; Arias A; Muñoz C; Rozman M; Belkaid M; Coutinho R; Nomdedeu B; Campo E
Leuk Res; 2010 Nov; 34(11):1437-41. PubMed ID: 20226525
[TBL] [Abstract][Full Text] [Related]
26. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
Seegmiller AC; Wasserman A; Kim AS; Kressin MK; Marx ER; Zutter MM; Mosse CA
Leuk Lymphoma; 2014 Mar; 55(3):601-5. PubMed ID: 23876099
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
Pitchford CW; Hettinga AC; Reichard KK
Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
[TBL] [Abstract][Full Text] [Related]
28. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization.
Wilkens L; Burkhardt D; Tchinda J; Büsche G; Werner M; Nolte M; Ganser A; Georgii A
Diagn Mol Pathol; 1999 Mar; 8(1):47-53. PubMed ID: 10408793
[TBL] [Abstract][Full Text] [Related]
31. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization for detecting chromosome abnormalities in myelodysplastic syndromes: A retrospective study.
Ai X; Li B; Xu Z; Liu J; Qin T; Li Q; Xiao Z
Medicine (Baltimore); 2021 May; 100(18):e25768. PubMed ID: 33950965
[TBL] [Abstract][Full Text] [Related]
32. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
Panani AD; Pappa V
In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
[TBL] [Abstract][Full Text] [Related]
33. [Myelodysplastic syndrome with early presentation of refractory monolineage cytopenia-with report of 13 cases].
Cheng SC; Yu YF; Li SL; Wang YZ; Ge CW; Feng SF; Liu HL; Liang WT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):303-6. PubMed ID: 12513762
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
Schwabkey ZI; Al Ali N; Chan O; Sallman DA; Padron E; Kuykendall AT; Talati C; Sweet K; Lancet JE; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e52-e56. PubMed ID: 33093008
[TBL] [Abstract][Full Text] [Related]
35. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
36. A patient with myelodysplastic syndrome studied by GTG-banding and fluorescent in situ hybridization (FISH).
Mark HF; Mark Y; Sotomayor E; Sambandam S
Cytobios; 1998; 94(376):121-8. PubMed ID: 9839434
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
[TBL] [Abstract][Full Text] [Related]
38. Comparison of I-FISH and G-banding for the detection of chromosomal abnormalities during the evolution of myelodysplastic syndrome.
Pinheiro RF; Chauffaille ML
Braz J Med Biol Res; 2009 Nov; 42(11):1110-2. PubMed ID: 19855907
[TBL] [Abstract][Full Text] [Related]
39. Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study.
Cherry AM; Brockman SR; Paternoster SF; Hicks GA; Neuberg D; Higgins RR; Bennett JM; Greenberg PL; Miller K; Tallman MS; Rowe J; Dewald GW
Leuk Res; 2003 Dec; 27(12):1085-90. PubMed ID: 12921944
[TBL] [Abstract][Full Text] [Related]
40. [Karyotype analysis and fluorescence in situ hybridization detection of 122 patients with myelodysplastic syndrome].
Jing Y; Lin S; Jiang F; Wang F; Fang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):221-6. PubMed ID: 27060321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
